JP2013543491A5 - - Google Patents

Download PDF

Info

Publication number
JP2013543491A5
JP2013543491A5 JP2013530571A JP2013530571A JP2013543491A5 JP 2013543491 A5 JP2013543491 A5 JP 2013543491A5 JP 2013530571 A JP2013530571 A JP 2013530571A JP 2013530571 A JP2013530571 A JP 2013530571A JP 2013543491 A5 JP2013543491 A5 JP 2013543491A5
Authority
JP
Japan
Prior art keywords
medicament
medicament according
administered
compound
value
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013530571A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013543491A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/DK2011/050375 external-priority patent/WO2012041334A1/en
Publication of JP2013543491A publication Critical patent/JP2013543491A/ja
Publication of JP2013543491A5 publication Critical patent/JP2013543491A5/ja
Pending legal-status Critical Current

Links

JP2013530571A 2010-10-01 2011-09-30 急性外傷性凝固障害及び蘇生した心停止の予防または処置に使用するための血管内皮の完全性を調節または保存できる化合物 Pending JP2013543491A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA201070427 2010-10-01
DKPA201070427 2010-10-01
PCT/DK2011/050375 WO2012041334A1 (en) 2010-10-01 2011-09-30 Compounds capable of modulating/preserving endothelial integrity for use in prevention or treatment of acute traumatic coagulopathy and resuscitated cardiac arrest

Publications (2)

Publication Number Publication Date
JP2013543491A JP2013543491A (ja) 2013-12-05
JP2013543491A5 true JP2013543491A5 (https=) 2014-06-05

Family

ID=44872128

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013530571A Pending JP2013543491A (ja) 2010-10-01 2011-09-30 急性外傷性凝固障害及び蘇生した心停止の予防または処置に使用するための血管内皮の完全性を調節または保存できる化合物

Country Status (9)

Country Link
US (1) US20130261177A1 (https=)
EP (1) EP2622354A1 (https=)
JP (1) JP2013543491A (https=)
KR (1) KR20140025303A (https=)
CN (2) CN103238070B (https=)
AU (1) AU2011307494B2 (https=)
BR (1) BR112013007849A2 (https=)
CA (1) CA2812846A1 (https=)
WO (1) WO2012041334A1 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102584844B1 (ko) 2009-06-12 2023-10-04 맨카인드 코포레이션 한정된 비표면적을 갖는 디케토피페라진 마이크로입자
CA2832992A1 (en) * 2011-04-19 2012-10-26 Rigshospitalet Prostacyclin and analogs thereof administered during surgery for prevention and treatment of capillary leakage
EP2834642A1 (en) * 2012-03-30 2015-02-11 Rigshospitalet Compounds capable of modulating/preserving endothelial integrity for use in prevention or treatment of acute traumatic coagulopathy and resuscitated cardiac arrest
CN104837806A (zh) 2012-12-07 2015-08-12 开曼化学股份有限公司 前列环素类似物的合成方法
EP3712142B1 (en) * 2013-01-11 2022-07-06 Corsair Pharma, Inc. Prodrugs of treprostinil
US9505737B2 (en) 2013-01-11 2016-11-29 Corsair Pharma, Inc. Treprostinil derivative compounds and methods of using same
EP3587404B1 (en) 2013-03-15 2022-07-13 MannKind Corporation Microcrystalline diketopiperazine compositions, methods for preparation and use thereof
MX375448B (es) 2013-07-18 2025-03-06 Mannkind Corp Composiciones farmacéuticas en polvo seco estables al calor y métodos.
WO2015073314A1 (en) 2013-11-13 2015-05-21 Cayman Chemical Company Incorporated Amine salts of a prostacyclin analog
CN107250375A (zh) 2014-11-06 2017-10-13 科罗拉多州立大学董事会 在血栓溶解剂存在下使用粘弹性分析鉴定新疾病状态
WO2016123163A2 (en) 2015-01-27 2016-08-04 Kardiatonos, Inc. Biomarkers of vascular disease
WO2016126849A1 (en) * 2015-02-03 2016-08-11 The Regents Of The University Of Colorado, A Body Corporate Use of viscoelastic analysis for predicting massive hemorrhage
EP3278112B1 (en) 2015-03-29 2021-09-22 Endothel Pharma ApS A composition comprising prostacyclin or analogues thereof for treatment of acute critically ill patients
US11187710B2 (en) 2015-06-08 2021-11-30 The Regents Of The University Of Colorado, A Body Corporate Time independent viscoelastic analysis parameter for prediction of patient outcome
EP3455366A4 (en) 2016-05-11 2020-02-26 Michael P. Chapman ANALYSIS OF VISCOELASTICITY IN PATIENTS WITH A DISEASE ASSOCIATED WITH THE CARDIOVASCULAR SYSTEM
US10806801B2 (en) * 2017-06-07 2020-10-20 National Cheng Kung University Pharmaceutical composition and methods for using the same
US12440285B2 (en) * 2021-01-22 2025-10-14 Cilag Gmbh International Prediction of hemostasis issues based on biomarker monitoring
US12105099B2 (en) * 2021-04-28 2024-10-01 Diotex Diagnostics, Llc Methods and devices for quantitatively estimating syndecan-1
CN114113641B (zh) * 2021-10-28 2023-11-03 中科精瓒(武汉)医疗技术有限公司 一种活化凝血检测试剂及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58164512A (ja) * 1982-03-25 1983-09-29 Ono Pharmaceut Co Ltd プロスタグランジン類似化合物を有効成分として含有する肝臓疾患治療剤
WO1993025220A1 (en) * 1992-06-05 1993-12-23 Reid Thomas J Iii Test for quantitative thrombin time
JPH11322612A (ja) * 1998-03-13 1999-11-24 Toray Ind Inc 肝細胞増殖因子誘引剤
CN2757804Y (zh) * 2004-11-19 2006-02-15 杨俊玉 心脏按压复苏指示装置
EP2063273A1 (en) * 2007-11-21 2009-05-27 Pentapharm GmbH Method for assessing the fibrinogen contribution in coagulation
US20100144597A1 (en) * 2008-12-10 2010-06-10 Ward Kevin R Novel combinatorial approaches to enhancing oxygen transport to tissues
RU2011132125A (ru) * 2008-12-30 2013-02-10 Тромбологик Апс Способы идентификации критических пациентов с повышенным риском развития органной недостаточности и соединения для их лечения
EP2525806B1 (en) * 2010-01-20 2014-06-04 INSERM (Institut National de la Santé et de la Recherche Médicale) Angiopoietin-like-protein-4 (ANGPTL4) for the preservation of vascular endothelial-cell barrier integrity

Similar Documents

Publication Publication Date Title
JP2013543491A5 (https=)
Yin et al. Efficacy and tolerability of sufentanil, dexmedetomidine, or ketamine added to propofol-based sedation for gastrointestinal endoscopy in elderly patients: a prospective, randomized, controlled trial
JP2013522212A5 (https=)
FI3645002T3 (fi) Menetelmiä sydämen vajaatoiminnan hoitamiseksi sydämen sarkomeerin aktivaattoreilla
JP2016512564A5 (https=)
FI3626270T3 (fi) Sydän- ja verisuonitautien hoito
Lee et al. Cardiorespiratory and anesthetic effects produced by the combination of butorphanol, medetomidine and alfaxalone administered intramuscularly in Beagle dogs
JP2014077003A5 (https=)
RU2015134581A (ru) Доноры нитроксила с улучшенным терапевтическим индексом
JP2016516016A5 (https=)
JP2013532658A5 (https=)
JP2016520089A5 (https=)
JP2016527202A5 (https=)
JP2012502103A5 (https=)
JP2018531605A5 (https=)
RU2015127834A (ru) Способы лечения диабета путем введения антагониста рецептора глюкагона в сочетании с ингибитором поглощения холестерина
Amin et al. Comparative study of neuromuscular blocking and hemodynamic effects of rocuronium and cisatracurium under sevoflurane or total intravenous anesthesia
FI3590960T3 (fi) Perifeeristen hermojen IgG-stimuloitu remyelinaatio
JP2016520114A5 (https=)
JP2016510040A5 (https=)
JP2023020885A5 (https=)
JP2015512923A5 (https=)
CN103655549B (zh) Myrtucommuacetalone在治疗或预防急性心衰药物中的应用
CN103520161B (zh) 一种解决长效酰胺类局麻药所致心脏停搏的药物组合
JP2016503406A5 (https=)